Kiora Pharmaceuticals Statistics
Total Valuation
KPRX has a market cap or net worth of $11.12 million. The enterprise value is -$2.37 million.
| Market Cap | 11.12M |
| Enterprise Value | -2.37M |
Important Dates
The next estimated earnings date is Friday, August 7, 2026, before market open.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KPRX has 4.43 million shares outstanding. The number of shares has decreased by -1.20% in one year.
| Current Share Class | 4.43M |
| Shares Outstanding | 4.43M |
| Shares Change (YoY) | -1.20% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 2.99% |
| Owned by Institutions (%) | 10.54% |
| Float | 4.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.72 |
| P/TBV Ratio | 0.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.68, with a Debt / Equity ratio of 0.03.
| Current Ratio | 6.68 |
| Quick Ratio | 6.19 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -496.34 |
Financial Efficiency
Return on equity (ROE) is -58.78% and return on invested capital (ROIC) is -32.45%.
| Return on Equity (ROE) | -58.78% |
| Return on Assets (ROA) | -22.41% |
| Return on Invested Capital (ROIC) | -32.45% |
| Return on Capital Employed (ROCE) | -53.76% |
| Weighted Average Cost of Capital (WACC) | 2.17% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$850,781 |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.41M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.49% in the last 52 weeks. The beta is -0.39, so KPRX's price volatility has been lower than the market average.
| Beta (5Y) | -0.39 |
| 52-Week Price Change | -15.49% |
| 50-Day Moving Average | 2.57 |
| 200-Day Moving Average | 2.32 |
| Relative Strength Index (RSI) | 45.01 |
| Average Volume (20 Days) | 22,657 |
Short Selling Information
The latest short interest is 20,871, so 0.47% of the outstanding shares have been sold short.
| Short Interest | 20,871 |
| Short Previous Month | 18,090 |
| Short % of Shares Out | 0.47% |
| Short % of Float | 0.49% |
| Short Ratio (days to cover) | 0.74 |
Income Statement
| Revenue | n/a |
| Gross Profit | -4.04M |
| Operating Income | -9.91M |
| Pretax Income | -12.47M |
| Net Income | -11.06M |
| EBITDA | -9.87M |
| EBIT | -9.91M |
| Earnings Per Share (EPS) | -$2.66 |
Balance Sheet
The company has $13.87 million in cash and $373,586 in debt, with a net cash position of $13.50 million or $3.05 per share.
| Cash & Cash Equivalents | 13.87M |
| Total Debt | 373,586 |
| Net Cash | 13.50M |
| Net Cash Per Share | $3.05 |
| Equity (Book Value) | 13.93M |
| Book Value Per Share | 3.49 |
| Working Capital | 15.88M |
Cash Flow
In the last 12 months, operating cash flow was -$10.42 million and capital expenditures -$115,807, giving a free cash flow of -$10.53 million.
| Operating Cash Flow | -10.42M |
| Capital Expenditures | -115,807 |
| Depreciation & Amortization | 35,046 |
| Net Borrowing | n/a |
| Free Cash Flow | -10.53M |
| FCF Per Share | -$2.38 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KPRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.20% |
| Shareholder Yield | 1.20% |
| Earnings Yield | -99.42% |
| FCF Yield | -94.70% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 11, 2024. It was a reverse split with a ratio of 1:9.
| Last Split Date | Jun 11, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:9 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |